Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics
Sign Up to like & getrecommendations! Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-53759-1
Abstract: Pulmonary exacerbations (PEx) are clinically impactful events for individuals with CF. Unfortunately, many CF individuals with PEx fail to regain their baseline lung function despite treatment. The objective of this study was to use unbiased… read more here.
Keywords: response; novel blood; treatment; quantitative proteomics ... See more keywords
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Hematology"
DOI: 10.1097/moh.0000000000000737
Abstract: Purpose of review Hemorrhage is a major cause of preventable death in trauma and cancer. Trauma induced coagulopathy and cancer-associated endotheliopathy remain major therapeutic challenges. Early, aggressive administration of blood-derived products with hypothesized increased clotting… read more here.
Keywords: freeze dried; prophylaxis; dried plasma; novel blood ... See more keywords
Novel blood typing method by discrimination of hemagglutination and rouleaux using an erythrocyte aggregometer.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical hemorheology and microcirculation"
DOI: 10.3233/ch-221651
Abstract: BACKGROUND In pretransfusion blood typing, pretreatments such as centrifugation and suspension of red blood cells (RBCs) and mixing them with sufficient amounts of reagents are required, but these steps are time-consuming and costly. OBJECTIVE Aiming… read more here.
Keywords: typing method; blood typing; novel blood; discrimination hemagglutination ... See more keywords